	The therapeutic potential of natural products for pediatric psoriasis: targeting the immune microenvironment. Front Pediatr Wang Z, Zhang J, Liu S, Chen H. PMID: 42422443 [PubMed]
	Cost-Utility Analyses of Systemic Treatments for Psoriasis and Psoriatic Arthritis in the UK: A Systematic Review of Modelling Methods. Pharmacoeconomics Clemmet TS, Phan DB, Copson A, Warren RB, Yiu ZZN, Rogers G. PMID: 42420624 [PubMed - as supplied by publisher]
	Harnessing Administrative Data for Real-World Evidence in Psoriatic Disease: Opportunities, Challenges, and Methodological Considerations. J Rheumatol McGagh D, Macfarlane GJ, Ogdie A. PMID: 42414045 [PubMed - as supplied by publisher]
	Pediatric Psoriasis: Comorbidities, Treatment Challenges and Unmet Needs. Dermatol Ther (Heidelb) Hernández-Santacana M, Balado-Simó P, Mansilla-Polo M, Riera-Monroig J. PMID: 42410289 [PubMed - as supplied by publisher]
	Can Systemic Treatment for Childhood Psoriasis Be Stopped in Cases of Remission? Data From the ACMe Cohort. Pediatr Dermatol Rached A, Miao Y, Beauchet A, Piram M, McPherson T, Torres T, Yesli Y, Aubert H, Bodemer C, Bertoli C, Tardieu M, Hubiche T, Bonniaud B, Neri I, Chessa MA, Lasek A, Prignano F, Barbarot S, Bursztejn AC, Leducq S, Sergeant M, Puzenat E, Chiaverini C, Sigg N, Mallet S, Miquel J, Pourchot D, Patel KX, Burden-Teh E, Flohr C, Di Lernia V, Mahé E, Groupe de Recherche de la Société Française de Dermatologie Pédiatrique, GrPso of the Société Française de Dermatologie. PMID: 42409581 [PubMed - as supplied by publisher]
	Improving outcomes of patients living with psoriatic arthritis: The Observational Best Practices Research Initiative (OBRI-PsA) registry: Rationale, Methodology and Preliminary Data of 18 Months Follow-up. PLoS One Attar RZ, Movahedi M, Cesta A, Li X, Sabido-Sauri R, Tsechelidis OB, Lau A, Chow A, Thorne C, Haaland D, Soucy E, Bombardier C, Aydin SZ, OBRI Investigators. PMID: 42406812 [PubMed - indexed for MEDLINE]
	Psoriatic arthritis patients have increased morbidity already at the time of diagnosis: a case-control study. Rheumatol Int Laine A, Muilu P, Kautiainen H, Rantalaiho V. PMID: 42406116 [PubMed - indexed for MEDLINE]
	Intelligent Diagnosis and Treatment of Psoriasis Research: A Bibliometric Analysis from 2005-01-01 to 2025-12-31. Clin Cosmet Investig Dermatol Jiang S, Tian Y, Zhao Q, Chen C, Lu T, Xiang Y. PMID: 42405326 [PubMed]
	Repurposing Old Drugs: Roflumilast as a Promising Therapeutic Option for Plaque Psoriasis. Clin Cosmet Investig Dermatol Li S, Wu N, Liu X, Jiang W. PMID: 42405325 [PubMed]
	Investigating the relationship between psoriatic arthritis, multiple long-term conditions, treatment burden and adverse clinical outcomes: A systematic review protocol. J Multimorb Comorb Opoku-Pare GA, Jani BD, Siebert S, Mair FS, Booth I, Canning J, Nicholl BI. PMID: 42404215 [PubMed]
	A Systematic Literature Review on Methotrexate Hepatotoxicity in Psoriasis Management: Preconceived Notion or Real Threat? Acta Derm Venereol Boehncke WH, Constantin MM, Carrascosa-Carrillo JM, Rakvit P, Varlet AA, Le Clanche S, Verhagen LAW, Viguier M. PMID: 42403312 [PubMed - indexed for MEDLINE]
	Comparative Transcriptomics Reveals SKH-1 Mice as a Valuable Model for Psoriasis Pathogenesis and Recurrence Studies. Exp Dermatol Yue L, Bai Y, Pang B, Qiao P, Xue K, Hu L, Wang G, Dang E. PMID: 42402932 [PubMed - indexed for MEDLINE]
	Comparative risk of reactivation of hepatitis B and C after treatment with biologics and targeted synthetic DMARDs in psoriasis and psoriatic arthritis: a 15-year multicenter cohort study. J Am Acad Dermatol Xue Y. PMID: 42398781 [PubMed - as supplied by publisher]
	Interpreting Radiographic Outcomes Across IL-23 Inhibitor Trials in Psoriatic Arthritis: The Role of Trial Design. J Am Acad Dermatol Oberlin D, Veenstra J. PMID: 42398773 [PubMed - as supplied by publisher]
	Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials. Br J Dermatol Stein Gold L, Armstrong AW, Soung J, Vender RB, González Cantero Á, Hoffmann M, Guenthner ST, Hong HC, Murrell DF, Song EJ, Kircik L, Augustin M, Sauder M, Gerdes S, Reyes-Servin O, Edem BE, Campbell J, Cresswell K, Kephart L, Li S, Yang YW, Bissonnette R. PMID: 42397072 [PubMed - as supplied by publisher]
	Ustekinumab Biosimilars versus Reference Ustekinumab for Moderate-to-Severe Plaque Psoriasis: A Pre-switch Systematic Review and Meta-analysis. BioDrugs Montes-de-Oca-Saucedo CR, Ghanem L, Kirmani N, Briceño-Villardaga B, Talancon-Solana AM, Salinas-Ocampo AJ, Sereno-Acevedo G, Soto-Domínguez A, Rivera-Díaz R. PMID: 42393486 [PubMed - as supplied by publisher]
	Matching-Adjusted Indirect Comparison of Risankizumab Versus Icotrokinra in Adult Patients with Moderate-to-Severe Plaque Psoriasis. Dermatol Ther (Heidelb) Crowley J, Song EJ, Stein-Gold L, Gisondi P, Bunick CG, Garg V, Leoncini E, Kaplan B, Ta R, Truong B, Sharma D, Strober B. PMID: 42393457 [PubMed - as supplied by publisher]
	Immunobiological Therapy in Moderate-to-Severe Psoriasis: A Retrospective Cohort Study Investigating the Effects of Inadequate Therapeutic Compliance on Drug Survival. Dermatol Ther (Heidelb) Ribeiro LA, Kurizky PS, de Sena RR, Fares S, Dos Santos GBF, Galvão LO, da Mota LMH, Gomes CM. PMID: 42390709 [PubMed - as supplied by publisher]
	Clinical Characteristics, Healthcare Resource Utilization, and Costs of Patients with Generalized Pustular Psoriasis in Taiwan: A National Claims Database Study. Psoriasis (Auckl) Chien HT, Tseng CY, Lu CW, Chung WH, Lin FJ. PMID: 42389669 [PubMed]
	Modified Delphi Consensus Recommendations for the Management of Psoriasis in Asia-Pacific. Dermatol Ther (Heidelb) Baek YS, Choon SE, Foley PA, Tsai TF, Zhang J, Yamaguchi Y. PMID: 42387165 [PubMed - as supplied by publisher]

Articles 1 - 20 / 28185

Page 1 of 1410



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy